| Masimo
and Philips Announce Broad Long Term Relationship To Offer Masimo SET in Philips
Patient Monitors
ANDOVER, Massachusetts, January 7, 2003 - Royal Philips
Electronics (NYSE: PHG, AEX: PHI), announced today that its medical systems
division, a leader in patient monitoring, and Masimo, a leader of motion and low
perfusion tolerant pulse oximetry, have signed a long-term, comprehensive
worldwide agreement that will make Masimo SET pulse oximetry available to
Philips' patient monitoring customers. A Masimo SET Module for Philips
IntelliVue™ monitors was debuted at the American Society of Anesthesiologists
annual meeting in October 2003, and is intended to be available for worldwide
sale, pending regulatory approval. For the large installed base of Philips CMS
and V24/V26 patient monitors, Masimo SET technology is available through a
specific Philips VueLink interface module or the Masimo SatShare™ interface.
Additionally, Masimo will sell Masimo's LNOP sensors to Philips installed
customer base.
"We are very excited to be able to offer our customers the
choice of Masimo SET pulse oximetry, said Ken Ferry, senior vice president and
general manager, patient monitoring for Philips Medical Systems. "Masimo has
pioneered motion and low perfusion tolerant technology and enjoys tremendous
support within the clinical and research community. With this agreement, Philips
underlines its clinical and technological excellence by offering our customers
the widest choice of pulse oximetry technologies and sensors in the patient
monitoring industry."
"Philips has a very strong worldwide market presence due
to their pursuit of excellence. They are consistently ranked among the
top-performing patient monitoring manufacturers, their most recent award being a
'best-of' ranking in over 60 percent of the categories in IMV's customer
satisfaction survey performed in the USA," said Joe E. Kiani, Chief Executive
Officer of Masimo. "Philips has listened to its customers and has decided to
adopt Masimo SET technology as they requested. We are proud to have Philips as a
partner in advancing the standard of care."
About Philips Medical Royal Philips Electronics of the
Netherlands is one of the world's biggest electronics companies and Europe's
largest, with sales of $30.1 billion (EUR 31.8 billion) in 2002. It is a global
leader in color television sets, lighting, electric shavers, medical diagnostic
imaging and patient monitoring, and one-chip TV products. Its 166,500 employees
in more than 60 countries are active in the areas of lighting, consumer
electronics, domestic appliances, semiconductors, and medical systems. Philips
is quoted on the NYSE (symbol: PHG), Frankfurt, Amsterdam and other stock
exchanges. News from Philips is located at www.philips.com/newscenter.
ATTN
Broadcasters: Philips b-roll (via beta copy, fiber transmission and satellite
feed), is available 24/7 by calling (+1-212-375-0021).
About Masimo
Corporation Masimo, founded in 1989, is the innovator and leader of
motion and low perfusion tolerant pulse oximetry. Masimo develops, licenses and
markets advanced medical signal processing technologies and products for the
non-invasive monitoring of vital signs. Masimo Signal Extraction Technology
represents a fundamental departure from conventional pulse oximetry
technologies. Over 70 independent and objective, published studies have
demonstrated that Masimo Signal Extraction Technology is the safest and most
effective pulse oximeter in the world. To date, Masimo has licensed its Signal
Extraction Pulse Oximetry technology to over 35 international patient monitoring
system providers, which make up over 70% of the world's pulse oximeter
shipments. Masimo is headquartered in Irvine, California. Additional information
about Masimo and its products can be found on www.masimo.com.
|